India · Delayed Price · Currency is INR Narayana Hrudayalaya Earnings Call Transcripts
Fiscal Year 2026
-
Margin expansion in India was driven by high-end procedures and payer mix, while U.K. integration is ongoing with cost synergies expected. Cayman insurance losses are being addressed through pricing and client rationalization, and clinics continue to act as key feeders for hospital growth.
-
India delivered strong profit and margin expansion, led by transformation and high-end procedures, while UK and Cayman segments focus on operational improvements and market share gains. CapEx and expansion are funded by internal accruals and debt, with no equity raise planned.
-
Q2 FY2026 delivered strong revenue and EBITDA growth, led by Cayman and India operations, with robust hospital margins and improving insurance performance. India saw 20% EBITDA growth, while the Cayman business posted 70% revenue growth year-over-year.
-
Q1 FY 2026 featured stable hospital margins, strong ARPP growth, and expansion in Cayman and India. Integrated Care and insurance businesses are scaling but currently dilute consolidated margins, with break-even expected in coming quarters. Oncology and digital initiatives continue to drive growth.
Fiscal Year 2025
-
The acquisition of a U.K. hospital group division is funded offshore, debt-free, and aims to replicate operational efficiencies from previous international ventures. The deal targets margin expansion, increased private payer mix, and scalable growth in a stable, regulated market.
-
Cayman business set a strong revenue base and stable margins, while India operations focus on organic growth, premiumization, and selective payer mix. Insurance and clinics are in investment mode, with CapEx funded mainly by debt. Working capital was impacted by delayed government payments, and international patient revenue is declining, positively affecting margins.
-
Q3 FY25 delivered strong margin recovery and revenue growth, driven by new facility ramp-ups in both India and Cayman. Expansion remains focused on core markets, with disciplined CapEx and new ventures in clinics and insurance showing early traction.
-
Strong revenue growth in India was driven by new hospitals and a shift to higher-value domestic patients, while the Cayman facility prepares for full commissioning with most costs already incurred. CapEx plans target 1,500 new beds, and integrated care and insurance businesses are scaling up.
-
Record quarterly revenue and improved EBITDA margin were achieved despite seasonal headwinds, with strong liquidity and ongoing expansion in India and overseas. New hospitals and digital initiatives are expected to drive future growth, while margin expansion is supported by payer mix optimization and operational efficiency.